多参数磁共振成像检测放射性粒子近距离治疗对胰腺导管腺癌异种移植瘤的疗效
研究将20只SW-1990胰腺导管腺癌皮下异种移植瘤小鼠随机分为碘-125粒子组(n=10)和空白对照组(n=10),于治疗前1天及治疗后14天、60天行扩散加权磁共振成像(DW-MRI)和动态对比增强磁共振成像(DCE-MRI),并与组织病理学对照。结果显示碘-125粒子近距离治疗组肿瘤平均表观扩散系数(ADC)值较对照组显著升高,灌注参数Ktrans和Kep显著降低,ADC与凋亡细胞密度、Ktrans和Kep与微血管密度均呈线性相关;作者认为DW-MRI和DCE-MRI可用于监测该治疗的疗效。
要点
- 碘-125粒子近距离治疗后14天和60天,治疗组肿瘤平均ADC值较空白对照组显著升高(p<0.05)。
- DCE-MRI显示治疗组灌注参数Ktrans和Kep较对照组显著降低(p<0.05)。
- 肿瘤周边区平均ADC与凋亡细胞密度线性相关(p=0.015,Spearman系数=0.945)。
核心结论
- 碘-125粒子近距离治疗可有效抑制胰腺导管腺癌细胞增殖,导致更高程度的坏死和坏死性凋亡,并降低微血管密度;DW-MRI和DCE-MRI可用于监测胰腺导管腺癌异种移植瘤对该治疗的疗效。
研究设计与样本
- 小鼠在体临床前研究:20只小鼠皮下植入SW-1990胰腺导管腺癌异种移植瘤,随机分为碘-125粒子组(n=10)和空白对照组(n=10),于治疗前1天及治疗后14天、60天行DW-MRI和DCE-MRI,影像结果与组织病理学对照。
关键影像表现/征象
- 治疗后14天和60天,碘-125粒子组肿瘤平均ADC值较空白对照组显著升高(p<0.05)。
- DCE-MRI显示碘-125粒子组灌注参数Ktrans和Kep较空白对照组显著降低(p<0.05)。
- 肿瘤周边区平均ADC与平均凋亡细胞密度呈线性正比(p=0.015,Spearman系数=0.945)。
- Ktrans和Kep与微血管密度(MVD)呈线性正比(p=0.043、0.047,Spearman系数=0.891、0.884)。
局限性
- 本文为小鼠模型临床前研究,作者同时提出该姑息治疗可能不仅适用于鼠类模型,也适用于人类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the therapeutic efficacy of Iodine-125 (125I) seeds brachytherapy to pancreatic ductal adenocarcinoma (PDAC) xenografts via multiparametric magnetic resonance imaging (MRI) analysis.
MATERIALS AND METHODS: Twenty mice were implanted subcutaneously with SW-1990 PDAC xenografts. The tumor-bearing mice were randomly divided into 125I seeds group (n = 10) and blank control group (n = 10). Treatment response was monitored by diffusion-weighted magnetic resonance imaging (DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) obtained 1 day before, 14 and 60 days after treatment. Imaging results were correlated with histopathology.
RESULTS: 125I seeds brachytherapy resulted in a significant increase in mean tumor apparent diffusion coefficient (ADC) values compared to the control at 14 and 60 days after treatment (p < 0.05). DCE-MRI showed a significant decrease in the perfusion parameters including Ktrans and Kep (p < 0.05). The mean ADCs within the peripheral region of the tumors were linearly proportional to the mean apoptotic cell density (p = 0.015; Spearman's coefficient = 0.945). The Ktrans and Kep were linearly proportional to microvessel density (MVD) (p = 0.043, 0.047; Spearman's coefficient = 0.891, 0.884).
CONCLUSION: 125I seeds brachytherapy leads to effective inhibition of PDAC cell proliferation, higher degree of necrosis and necroptosis, and lower MVD. Both DW-MRI and DCE-MRI are feasible to monitor a response to 125I seeds brachytherapy in the PDAC xenografts. This paper shows an original project concerning about a possible palliative treatment not only in a murine model (preclinical setting) but also in humans.
引用
- Liu Y, Wang Y, Tang W, et al. Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts. Radiol Med. 2018. PMID: 29508241. doi:10.1007/s11547-018-0867-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。